Table 2.
CYP2C19 genotype (n=103) | 7-day plus probiotic (n=26) | 7-day plus placebo (n=25) | 14-day plus probiotic (n=26) | 14-day plus placebo (n=26) |
---|---|---|---|---|
PM no. (n=11; 10.7%) | 3 (100%) | 1 (0.00%) | 5 (100%) | 2 (100%) |
IM no. (n=48; 46.6%) | 12 (100%) | 13 (92.3%) | 9 (88.9%) | 14 (92.9%) |
RM no. (n=44; 42.7%) | 11 (100%) | 11 (90.9%) | 12 (91.7%) | 10 (100%) |
*number in parenteses are eradication rates